Guardian Pharmacy Services, Inc.: shareholders and insiders

GRDNNYSEConsumer defensive · Retail-Drug Stores and Proprietary Stores

Price

$49.43

November 16, 2026Market cap $3.1B

What Ploutos Investor adds for Guardian Pharmacy Services

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 24% since Nov 5, 2026, when the 10-Q these figures come from was filed ($39.87 then, $49.43 on Nov 16, 2026). The figures date from before that move.10-Q

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Sep 28, 2026, from their own Form 4 filings.

16 Form 4s

Bought on the market

$99.8K

1 person

Sold on the market

$175M

6 people

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 17, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $175M by 6 people

  • 2025: bought $99.8K by 1 person, no sales
  • 2026: no buys, sold $175M by 6 people
  • Sep 27, 2026William Franklin MuddSenior Vice President, Chief Financial Officer
    Kind
  • Sep 27, 2026Robert WeirSenior Vice President, Operations & Regulatory Support
    Kind
  • Sep 27, 2026John AckermanDirector
    Kind
  • Sep 27, 2026John AckermanDirector
    Kind
  • Sep 27, 2026Thomas J Salentine JrDirector
    Kind
  • Sep 27, 2026David Norman MartinSenior Vice President, Technology, Data & Senior Security Officer
    Kind
  • Sep 27, 2026Pharmacy Investors, LLC
    Kind
  • Sep 27, 2026Fred BurkePresident and Chief Executive Officer
    Kind
  • Sep 27, 2026Jeffrey TuchSenior Vice President, Purchasing & Pricing Analytics
    Kind
  • Sep 27, 2026Kendall Forbes
    Kind
  • Sep 27, 2026William E BindleyDirector
    Kind
  • Sep 27, 2026David K MorrisExecutive Vice President, Chief Operating Officer
    Kind
  • Sep 27, 2026Chris CrisafulliSenior Vice President, Payor and Industry Strategy
    Kind
  • Sep 27, 2026Richard EakinsSenior Vice President, Sales
    Kind
  • Sep 27, 2026Cardinal Equity Fund, L.P.
    Kind
  • Sep 27, 2026Bindley Capital Partners I, LLC
    Kind
  • Sep 27, 2026Douglas TownsSenior Vice President, General Counsel, Senior Compliance Officer & Corporate Secretary
    Kind
  • Mar 20, 2026Cardinal Equity Fund, L.P.
    Kind
  • Mar 20, 2026Kendall Forbes
    Kind
  • Mar 20, 2026William E Bindley
    Kind
  • Mar 20, 2026John Ackerman
    Kind
  • Mar 20, 2026Fred Burke
    Kind
  • Mar 20, 2026David K Morris
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Sep 28, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by GRDN's officers and directors from 2024 up to November 16, 2025, 2 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%1 On a 13DNov 5, 2026 Latest filing
  • Bindley Capital Partners I, LLCwith 8 more personsClass A Common Stock, par value $0.001 per share
    Share of class26.4%
  • FMRwith 1 more personCLASS A COMMON STOCK
    Share of class5.00%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Bindley Capital Partners I, LLC26.4%From the filing of Mar 24, 2026

    Item 4 of the Schedule 13D is amended and supplemented as follows: On March 20, 2026, the Reporting Persons sold an aggregate amount of 5,880,000 shares of Class A common stock of the Issuer pursuant to an underwriting agreement, dated as of March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters (the "Underwriters") named therein (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, on March 20, 2026, the Underwriters exercised in full their option to purchase an additional 900,000 shares of Class A common stock from the Reporting Persons.

    From the filing of Mar 24, 2026
Fell to 5% or less (13)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Brown Advisory4.54%Feb 13, 202613G/A
  • Wellington Management Group LLP3.10%Feb 10, 202613G/A
  • BlackRock, Inc.4.20%Jan 21, 202613G/A
  • J. Goldman & Co LP2.90%Nov 14, 202513G/A
  • Franklin Resources, Inc.4.30%Aug 5, 202513G/A
  • Clearbridge Investments, LLC2.00%Aug 5, 202513G/A
  • The Vanguard Group4.25%Jul 29, 202513G/A
  • Nuveen Asset Management, LLC0.31%Jun 6, 202513G/A
  • TIAA-CREF Investment Management, LLC2.06%Jun 6, 202513G/A
  • Teachers Advisors, LLC0.05%Jun 6, 202513G/A
  • Woodline Partners LP4.50%Feb 14, 202513G/A
  • Alyeska Investment Group, L.P.4.66%Feb 14, 202513G/A
  • Ophir Asset Management Pty Ltd1.80%Jan 2, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-85%
  • Millennium Mgmt (Englander)
    In the quarter+344%
  • D.E. Shaw
    In the quarter-2.4%
  • Renaissance Technologies
    In the quarter-16%
  • AQR Capital
    In the quarter-53%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 3.76% of its shares outstanding were held short, -3.9% since the report before.

Shares held short
2.38M
3.76%
Since the report before2.48M on Sep 30, 2026
-3.9%
5.3
448.5K
More days to cover thanof 4,578 US-listed companies with enough volume
64%
Report date
Oct 15, 2026
  • Sep 30, 2024: Shares held short 80.8K
  • Oct 15, 2024: Shares held short 9,437
  • Oct 31, 2024: Shares held short 5,525
  • Nov 15, 2024: Shares held short 33.8K
  • Nov 29, 2024: Shares held short 87.1K
  • Dec 13, 2024: Shares held short 132.2K
  • Dec 31, 2024: Shares held short 868.3K
  • Jan 15, 2025: Shares held short 753.9K
  • Jan 31, 2025: Shares held short 809.3K
  • Feb 14, 2025: Shares held short 775.8K
  • Feb 28, 2025: Shares held short 760.8K
  • Mar 14, 2025: Shares held short 798.3K
  • Mar 31, 2025: Shares held short 986.8K
  • Apr 15, 2025: Shares held short 988.0K
  • Apr 30, 2025: Shares held short 992.2K
  • May 15, 2025: Shares held short 956.0K
  • May 30, 2025: Shares held short 1.03M
  • Jun 13, 2025: Shares held short 558.1K
  • Jun 30, 2025: Shares held short 546.4K
  • Jul 15, 2025: Shares held short 538.6K
  • Jul 31, 2025: Shares held short 515.1K
  • Aug 15, 2025: Shares held short 496.8K
  • Aug 29, 2025: Shares held short 339.2K
  • Sep 15, 2025: Shares held short 536.6K
  • Sep 30, 2025: Shares held short 1.22M
  • Oct 15, 2025: Shares held short 1.13M
  • Oct 31, 2025: Shares held short 1.23M
  • Nov 14, 2025: Shares held short 1.16M
  • Nov 28, 2025: Shares held short 1.29M
  • Dec 15, 2025: Shares held short 1.36M
  • Dec 31, 2025: Shares held short 1.16M
  • Jan 15, 2026: Shares held short 1.54M
  • Jan 30, 2026: Shares held short 1.83M
  • Feb 13, 2026: Shares held short 1.87M
  • Feb 27, 2026: Shares held short 1.79M
  • Mar 13, 2026: Shares held short 1.96M
  • Mar 31, 2026: Shares held short 2.91M
  • Apr 15, 2026: Shares held short 2.52M
  • Apr 30, 2026: Shares held short 2.70M
  • May 15, 2026: Shares held short 2.77M
  • May 29, 2026: Shares held short 2.91M
  • Jun 15, 2026: Shares held short 3.24M
  • Jun 30, 2026: Shares held short 3.09M
  • Jul 15, 2026: Shares held short 2.79M
  • Jul 31, 2026: Shares held short 2.85M
  • Aug 14, 2026: Shares held short 3.01M
  • Aug 31, 2026: Shares held short 3.04M
  • Sep 15, 2026: Shares held short 2.43M
  • Sep 30, 2026: Shares held short 2.48M
  • Oct 15, 2026: Shares held short 2.38M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading59.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 59.5% of the shares in the reported trades were short sales, against 56.0% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
59.5%
The 14 beforeOct 8, 2026 – Oct 27, 2026
56.0%
Change
+3.5 pts
Short sales a dayon average, of 228.7K shares
136.2K
More than atof 3,668 US-listed companies, same days
81%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 44.1%
  • Oct 9, 2026: Short sales 38.2%
  • Oct 12, 2026: Short sales 39%
  • Oct 13, 2026: Short sales 74.5%
  • Oct 14, 2026: Short sales 43.3%
  • Oct 15, 2026: Short sales 47.4%
  • Oct 16, 2026: Short sales 80.2%
  • Oct 19, 2026: Short sales 62.1%
  • Oct 20, 2026: Short sales 51.1%
  • Oct 21, 2026: Short sales 63%
  • Oct 22, 2026: Short sales 86.1%
  • Oct 23, 2026: Short sales 67%
  • Oct 26, 2026: Short sales 66.1%
  • Oct 27, 2026: Short sales 79.7%
  • Oct 28, 2026: Short sales 76.1%
  • Oct 29, 2026: Short sales 83.8%
  • Oct 30, 2026: Short sales 82.5%
  • Nov 2, 2026: Short sales 73.5%
  • Nov 3, 2026: Short sales 75.3%
  • Nov 4, 2026: Short sales 79.5%
  • Nov 5, 2026: Short sales 69.6%
  • Nov 6, 2026: Short sales 37.8%
  • Nov 9, 2026: Short sales 57.2%
  • Nov 10, 2026: Short sales 50.6%
  • Nov 11, 2026: Short sales 49.6%
  • Nov 12, 2026: Short sales 58.7%
  • Nov 13, 2026: Short sales 45%
  • Nov 16, 2026: Short sales 64.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

67.25M Insiders' shares
  • Thomas J Salentine JrDirector
    Directly16.71M
  • William E BindleyDirector
    Directly16.67M
  • Bindley Capital Partners I, LLC
    Directly16.67M
  • John AckermanDirector
    Directly5.15M
  • Pharmacy Investors, LLC
    Directly3.86M
  • Fred BurkePresident and Chief Executive Officer
    Directly3.44M
  • Kendall Forbes
    Directly1.65M
  • Cardinal Equity Fund, L.P.
    Directly1.29M
  • David K MorrisExecutive Vice President, Chief Operating Officer
    Directly896.3K
  • Jeffrey TuchSenior Vice President, Purchasing & Pricing Analytics
    Directly231.8K
  • David Norman MartinSenior Vice President, Technology, Data & Senior Security Officer
    Directly140.9K
  • William Franklin MuddSenior Vice President, Chief Financial Officer
    Directly136.7K
  • Richard EakinsSenior Vice President, Sales
    Directly134.9K
  • Douglas TownsSenior Vice President, General Counsel, Senior Compliance Officer & Corporate Secretary
    Directly113.0K
  • Robert WeirSenior Vice President, Operations & Regulatory Support
    Directly103.3K
  • Chris CrisafulliSenior Vice President, Payor and Industry Strategy
    Directly53.1K

A lower bound: it counts only the 16 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

7 ETFs holding it0.05% The largest weight (IWO)
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.05%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.02%
  • DFACDimensional U.S. Core Equity 2 ETF
    Weight in the fund0.00%
  • AVUSAvantis U.S. Equity ETF
    Weight in the fund0.00%
  • DFUSDimensional U.S. Equity Market ETF
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%
  • IWViShares Russell 3000 ETF
    Weight in the fund0.00%

7 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

189 Managers, Q2 2026$1.2B Value of their positions
  • Q3 2025: Managers 112
  • Q4 2025: Managers 129
  • Q1 2026: Managers 172
  • Q2 2026: Managers 189

Institutional investors by quarter

The fund managers holding GRDN, quarter by quarter, from Q3 2024 to Q2 2025, 4 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 8 quarters.

Q2 2026: 189 managers held 29.51M shares, worth $1.2B. During the quarter 36 opened a position, 19 closed one, 69 added and 53 trimmed.

The largest holders, Q2 2026

  • FMR
    In the quarter+37%
  • Wellington Management Group
    In the quarter-2.0%
  • BlackRock
    In the quarter-10%
  • Vanguard Capital Management
    In the quarter+13%
  • Woodline Partners
    In the quarter
  • Valiant Capital Management
    In the quarter
  • T. Rowe Price Investment Management
    In the quarter+8.6%
  • Boston Partners
    In the quarter-3.3%
  • Franklin Resources
    In the quarter+1.4%
  • TimesSquare Capital Management
    In the quarter-12%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Guardian Pharmacy Services's filings show?

Who buys and sells is one part of Guardian Pharmacy Services's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about GRDN's shareholders

Didn't find what you were looking for?

Ask us
Have GRDN's insiders bought or sold?

From Sep 28, 2026 to Sep 28, 2026 Guardian Pharmacy Services's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold GRDN?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $5.0M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.